论文信息 - A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults - 字舞流文

A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults

R. Railkar | K. Vora | K. Cox | S. Stoch | A. Aliprantis | E. Lai | L. Caro | D. Montgomery | Brian M Maas | A. Hunt | B. Roadcap | L. Sterling | Andrew W Lee | Hua Ma | Dennis G Wolford | Radha A. Railkar | Dennis G. Wolford | A. Lee